Dry eye and ocular surface irritation require solutions compatible with repeated use and well tolerated.
Preserved formulations may limit instillation frequency and acceptability in certain patients.
In this context, preservative-free medical devices provide an approach suitable for frequent and long-term use.
A formulation containing Carragelose® enables:
Preservative-free multidose ophthalmic solution containing Carragelose®.
Objective: provide ocular protection compatible with frequent use
Key characteristics
✓
Protective film
Formation of a hydrating barrier on the ocular surface.
✓
Repeated use
Compatible with multiple daily administration.
✓
Tolerance
Preservative-free formulation suitable for prolonged use.
✓
Lubricating function
Can be used to prevent or relieve dry eye symptoms.
| Multi-dose | Volume | Category | Status | Dossier | Country |
|---|---|---|---|---|---|
| Sodium Carmellose (CMC) 0.5% | 10.15 ml | Ophthalmic | MD | October 2026 - ANVISA | Brazil, US |
| Sodium Hyaluronate 0.15% | 10 ml | Ophthalmic | MD | October 2026 - ANVISA | Brazil, US |
| Sodium Carmellose (CMC) 0.5% + Sodium Hyaluronate 0.10% + Glycerol 0.9% | 10 ml | Ophthalmic | MD | Q1 2027 - ANVISA | Brazil, US |
| Carragelose eye drops 3.2 mg/ml (Preservative free) | 10 ml | Ophthalmic | MD (IIa) | CE Marking | Contact us |
